Akèy › Anplwayè › Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc.: Salè H-1B ak pajon
Mirati Therapeutics, Inc. depoze 15 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 15. Medyèn salè yo ofri a: $150,000.
Èske Mirati Therapeutics, Inc. pajone visa H-1B?
Mirati Therapeutics, Inc. depoze 15 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 5, 2024. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Demands Green Card (PERM) pou Mirati Therapeutics, Inc.: 4 →
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Manager, Pharmacovigilance Submissions | 2 | $134,000 |
| Senior Manager, Clinical Data Management | 2 | $175,658 |
| Associate Director, Biostatistics | 1 | $190,000 |
| Biochemist, Senior Scientist | 1 | $109,000 |
| Executive Medical Director | 1 | $288,444 |
| Senior Scientist, Chemical Process R&D | 1 | $125,000 |
| Sr. Manager, Statistical Programming | 1 | $164,274 |
| Principal Clinical Data Manager | 1 | $139,755 |
| Sr. Manager, Pharmacovigilance | 1 | $150,000 |
| Senior Manager, Analytical R&D and QC | 1 | $185,640 |
| Principal Scientist, Product Development | 1 | $164,000 |
| Senior Scientist, Analytical R&D and QC | 1 | $146,016 |
| Senior Scientist, Analytical Development | 1 | $146,932 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 6 | $149,137 |
| FY2024 | 9 | $150,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Chemists4
- Data Scientists4
- Medical and Health Services Managers2
- Natural Sciences Managers2
- Statisticians1
- Biochemists and Biophysicists1
- Regulatory Affairs Specialists1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Manager, Analytical R&D and QC | $185,640 Nivo II | San Diego, CA | Jun 5, 2024 | Nov 22, 2024 | Certifye |
| Principal Scientist, Product Development | $164,000 Nivo IV | San Diego, CA | May 24, 2024 | Nov 8, 2024 | Certifye |
| Senior Scientist, Analytical R&D and QC | $146,016 Nivo IV | San Diego, CA | May 22, 2024 | Oct 11, 2024 | Certifye |
| Senior Manager, Clinical Data Management | $188,843 Nivo IV | San Diego, CA | May 9, 2024 | Oct 15, 2024 | Certifye |
| Senior Scientist, Analytical Development | $146,932 Nivo IV | San Diego, CA | May 6, 2024 | Jul 19, 2024 | Certifye |
| Manager, Pharmacovigilance Submissions | $134,000 Nivo IV | Overland Park, KS | Jan 9, 2024 | Jan 15, 2024 | Certifye |
| Principal Clinical Data Manager | $139,755–$202,020 Nivo III | San Diego, CA | Nov 13, 2023 | Apr 25, 2024 | Certifye |
| Senior Manager, Clinical Data Management | $162,474–$202,991 Nivo IV | San Diego, CA | Oct 11, 2023 | Mar 1, 2024 | Certifye |
| Sr. Manager, Statistical Programming | $164,274–$202,991 Nivo IV | San Diego, CA | Jun 28, 2023 | Dec 26, 2023 | Certifye |
| Executive Medical Director | $288,444–$414,598 Nivo IV | San Diego, CA | May 10, 2023 | Jun 6, 2023 | Certifye |
| Biochemist, Senior Scientist | $109,000–$152,000 Nivo II | San Diego, CA | Feb 24, 2023 | Aug 25, 2023 | Certifye |
| Manager, Pharmacovigilance Submissions | $134,000 Nivo III | San Diego, CA | Nov 2, 2022 | Nov 21, 2022 | Certifye |
| Associate Director, Biostatistics | $190,000 Nivo IV | San Diego, CA | Oct 28, 2022 | Nov 14, 2022 | Certifye |
| Sr. Manager, Pharmacovigilance | $150,000 Nivo III | San Diego, CA | Mar 14, 2022 | Jun 16, 2022 | Certifye, apre retire |
| Senior Scientist, Chemical Process R&D | $125,000 Nivo IV | San Diego, CA | Jan 7, 2022 | Feb 14, 2022 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).